Method for producing cyclometalated iridium complex, and cyclometalated iridium complex precursor including organoiridium material
US-10538543-B2 · Jan 21, 2020 · US
Method for producing cyclometalated iridium complex
US11008352B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11008352-B2 |
| Application number | US-201716344315-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 4, 2017 |
| Priority date | Dec 21, 2016 |
| Publication date | May 18, 2021 |
| Grant date | May 18, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
(in General Formula (1), Ir represents an iridium atom, and O represents an oxygen atom).
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for producing a cyclometalated iridium complex, the method comprising: producing a cyclometalated iridium complex by reacting a cyclometalated iridium complex raw material including an organoiridium compound with an aromatic heterocyclic bidentate ligand capable of forming an iridium-carbon bond and an iridium-nitrogen bond; and using as the raw material an organoiridium compound including a substructure represented by the following General Formula (1): (in General Formula (1), Ir represents an iridium atom, and O represents an oxygen atom), wherein the aromatic heterocyclic bidentate ligand is represented by General Formula (5), and the cyclometalated iridium complex is represented by General Formula (6): (in General Formula (5), N represents a nitrogen atom, C represents a carbon atom, H represents a hydrogen atom, CyA is any one of a pyridine ring, a quinoline ring, an isoquinoline ring, an imidazole ring, and a triazole ring, CyB is a benzene ring, and CyA and CyB are optionally linked together to form a ring structure); and (In General Formula (6), Ir represents an iridium atom, N represents a nitrogen atom, C represents a carbon atom, H represents a hydrogen atom, CyA is any one of a pyridine ring, a quinoline ring, an isoquinoline ring, an imidazole ring, and a triazole ring, and is linked to iridium via the nitrogen atom of the ring, and CyB is a benzene ring, and is linked to iridium via the carbon atom ring; and CyA and CyB may be linked together to further form a ring structure). 2. The method for producing a cyclometalated iridium complex according to claim 1 , comprising using as a raw material an organoiridium compound represented by the following General Formula (2): (in General Formula (2), Ir represents an iridium atom, and O represents an oxygen atom; L represents a monodentate or bidentate ligand; Y represents a counter cation; Z represents 0 to 3; m represents 1 to 3; and n represents 0 to 4). 3. The method for producing a cyclometalated iridium complex according to claim 1 , comprising using as a raw material an organoiridium compound represented by the following General Formula (3): (in General Formula (3), Ir represents an iridium atom, and O represents an oxygen atom; X represents a monodentate ligand; Y represents a counter cation; Q represents 2 or 3). 4. The method for producing a cyclometalated iridium complex according to claim 1 , comprising using as a raw material an organoiridium compound represented by the following General Formula (4): (in General Formula (4), Ir represents an iridium atom, and O represents an oxygen atom; Y represents a counter cation; R represents 2 or 3).
Assignees
Inventors
Classifications
- C07F15/0033Primary
Iridium compounds · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11008352B2 cover?
- (in General Formula (1), Ir represents an iridium atom, and O represents an oxygen atom).
- Who is the assignee on this patent?
- Aist
- What technology area does this patent fall under?
- Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).